The August 2025 recall spotlights four previously released episodes on topics related to dementia diagnosis. The episode begins with Dr. Amy Brodtmann discussing the complexities of diagnosing frontotemporal dementia in clinical practice. Next, Dr. Joseph Therriault delves into the use of plasma biomarkers in diagnosing Alzheimer disease. In the third episode, Dr. Trey Bateman discusses the growing significance of blood-based biomarkers in Alzheimer disease. The episode concludes with Dr. Gregg Day discussing the clinical implications of using plasma biomarkers in real-world patient care.

Podcast links:

Frontotemporal Dementia Differential Diagnosis in Clinical Practice

Diagnosis of Alzheimer Disease Using Plasma Biomarkers

Understanding Blood-Based Biomarkers in Alzheimer Disease

Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic

Article links:

Frontotemporal Dementia Differential Diagnosis in Clinical Practice

Diagnosis of Alzheimer’s Disease Using Plasma Biomarkers Adjusted to Clinical Probability

Diagnostic Performance of Plasma p-tau217 and Aβ42/40 Biomarkers in the Outpatient Memory Clinic

Disclosures can be found at Neurology.org.

Dr. Kathryn Krulisky talks with Dr. Jordan Garris about educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training.

Read the related article in Neurology® Education.

Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.

Read the related article in The New England Journal of Medicine.

Disclosures can be found at Neurology.org.